Background: T2 relaxation-based magnetic resonance imaging (MRI) signals may provide onset time for acute ischemic strokes with an unknown onset. The ability of visual and quantitative MRI-based methods in a cohort of hyperacute ischemic stroke patients was studied.Methods: A total of 35 patients underwent 3T (3 Tesla) MRI (<9-hour symptom onset). Diffusion-weighted (DWI), apparent diffusion coefficient (ADC), T1-weighted (T1w), T2-weighted (T2w), and T2 relaxation time (T2) images were acquired. T2-weighted fluid attenuation inversion recovery (FLAIR) images were acquired for 17 of these patients. Image intensity ratios of the average intensities in ischemic and non-ischemic reference regions were calculated for ADC, DWI, T2w, T2 relaxatio...
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if ...
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be a...
PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal hypoattenuat...
The apparent diffusion coefficient (ADC) of cerebral water, as measured by diffusion MRI, rapidly de...
Unknown onset time is a common contraindication for anti-thrombolytic treatment of ischaemic stroke....
Background and Purpose—Toward the goal of designing a clinical trial using imaging parameters to tre...
Many ischaemic stroke patients are ineligible for thrombolytic therapy due to unknown onset time. Q...
Background and objective:In hyperacute ischaemic stroke, T2 of cerebral water increases with time. Q...
The time course of changes in apparent diffusion coefficient (ADC) and signal intensity on diffusion...
Introduction: In acute stroke, the DWI-FLAIR mismatch allows for the identification of patients elig...
Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients...
Background and Purpose - Acute stroke patients with unknown time of symptom onset are ineligible for...
Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients...
BACKGROUND: Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if...
weighted MR imaging have been proposed as tools for advanced diagnosis in hyperacute is-chemic strok...
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if ...
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be a...
PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal hypoattenuat...
The apparent diffusion coefficient (ADC) of cerebral water, as measured by diffusion MRI, rapidly de...
Unknown onset time is a common contraindication for anti-thrombolytic treatment of ischaemic stroke....
Background and Purpose—Toward the goal of designing a clinical trial using imaging parameters to tre...
Many ischaemic stroke patients are ineligible for thrombolytic therapy due to unknown onset time. Q...
Background and objective:In hyperacute ischaemic stroke, T2 of cerebral water increases with time. Q...
The time course of changes in apparent diffusion coefficient (ADC) and signal intensity on diffusion...
Introduction: In acute stroke, the DWI-FLAIR mismatch allows for the identification of patients elig...
Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients...
Background and Purpose - Acute stroke patients with unknown time of symptom onset are ineligible for...
Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients...
BACKGROUND: Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if...
weighted MR imaging have been proposed as tools for advanced diagnosis in hyperacute is-chemic strok...
Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if ...
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be a...
PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal hypoattenuat...